Hunan Hansen Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 15.00%

Hunan Hansen Pharmaceutical Co Ltd (002412) has an Asset Resilience Ratio of 15.00% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥410.02 Million

≈ $60.00 Million USD Cash + Short-term Investments

Total Assets

CN¥2.73 Billion

≈ $399.99 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how Hunan Hansen Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Hunan Hansen Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Hunan Hansen Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Hunan Hansen Pharmaceutical Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥410.02 Million	15.0%
Total Liquid Assets	CN¥410.02 Million	15.00%

Asset Resilience Insights

Good Liquidity Position: Hunan Hansen Pharmaceutical Co Ltd maintains a healthy 15.00% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Hunan Hansen Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Hunan Hansen Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Hunan Hansen Pharmaceutical Co Ltd (2021–2025)

The table below shows the annual Asset Resilience Ratio data for Hunan Hansen Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	12.39%	CN¥333.80 Million ≈ $48.85 Million	CN¥2.69 Billion ≈ $394.08 Million	+2.81pp
2024-12-31	9.58%	CN¥244.12 Million ≈ $35.72 Million	CN¥2.55 Billion ≈ $372.74 Million	+0.86pp
2023-12-31	8.73%	CN¥203.87 Million ≈ $29.83 Million	CN¥2.34 Billion ≈ $341.90 Million	+2.80pp
2022-12-31	5.93%	CN¥135.82 Million ≈ $19.87 Million	CN¥2.29 Billion ≈ $335.24 Million	+3.60pp
2021-12-31	2.33%	CN¥49.24 Million ≈ $7.21 Million	CN¥2.11 Billion ≈ $308.95 Million	--

pp = percentage points

About Hunan Hansen Pharmaceutical Co Ltd

SHE:002412 China Drug Manufacturers - Specialty & Generic

Market Cap

$498.50 Million

CN¥3.41 Billion CNY

Market Cap Rank

#12087 Global

#3454 in China

Share Price

CN¥6.77

Change (1 day)

+0.30%

52-Week Range

CN¥5.50 - CN¥8.02

All Time High

CN¥51.53